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infected women enrolled in ‘Option B+’, Thyolo, Malawi
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M. Murowa,5 G. S. Mwenelupembe,1 R. Van den Bergh,1 L. Triviño Durán1
In 2012, 260 000 new cases of human immunodefi-ciency virus (HIV) infection in children occurred in 
sub-Saharan Africa, primarily due to mother-to-child 
transmission of HIV.1 However, childhood HIV infection 
can be prevented by the implementation of prevention 
of mother-to-child transmission (PMTCT) strategies.
PMTCT ‘Option B+’ originated in Malawi in July 
2011.2–5 With Option B+, all pregnant and breastfeed-
ing women are offered HIV testing and counselling, 
and those who are HIV-infected are offered life-long 
antiretroviral treatment (ART) with tenofovir/lamivu-
dine/efavirenz.2,6 HIV-exposed infants receive nevirap-
ine from birth until 6 weeks of age.2,6 National guide-
lines recommend that all HIV-exposed infants 
undergo HIV DNA polymerase chain reaction (PCR) 
testing 6–8 weeks after birth and rapid HIV testing 
(RHT) at 12–24 months of age, and that those with 
HIV infection be started on ART immediately.4,6
Option B+ was endorsed by the World Health Orga-
nization (WHO) in 2012 and included in the 2013 
WHO ART guidelines.3 By June 2013, 588 health facili-
ties were offering Option B+ in Malawi.7
A seven-fold increase in the number of women ini-
tiated on ART in the first year of Option B+ in Malawi 
was documented, with 77% retained in care at 12 
months.8 More evidence, however, is needed on the 
management of HIV-exposed infants under routine 
conditions of Option B+ implementation.2,3,9 The aim 
of this study was to evaluate programme retention 
and uptake and timing of HIV testing among infants 
born to HIV-infected mothers enrolled in Option B+ at 
Thyolo District Hospital (TDH).
ASPECTS OF INTEREST
This was a retrospective study of routinely collected 
programme data. At TDH, the Ministry of Health 
(MoH) introduced Option B+ in October 2011, with 
support from Médecins Sans Frontières (MSF). Infor-
mation on infants enrolled in Option B+ was ab-
stracted from patient cards and entered into an MS 
Access® (Microsoft Corp, Redmond, WA, USA) data-
base. All infants born at TDH to women in the Option 
B+ programme from October 2011 to June 2012 were 
included in the study. A descriptive analysis was per-
formed using EpiData version 2.2.2.182 (EpiData Asso-
ciation, Odense, Denmark) to assess programme reten-
tion at 12 months and the uptake and timing of HIV 
testing.
Ethics approval for the study was granted by the 
Malawi National Health Sciences Research Committee, 
the MSF Ethics Review Board, and the Ethics Advisory 
Group of the International Union Against Tuberculo-
sis and Lung Disease, Paris, France.
There were 513 infants, of whom 277 (53.9%) were 
female. Programme retention at 12 (±1) months is 
shown in Table 1. Altogether, 368 (71.7%) infants 
were retained in care at TDH, 86 (16.8%) were lost to 
follow-up, 48 (9.4%) were transferred out and 4 (0.8%) 
died.
Uptake of HIV testing is shown in Table 2. Of the 
513 infants, 412 (80.7%) had a record of PCR testing, 
with 267 (52.0%) tested at 6–12 weeks; 255 (49.7%) 
had a record of RHT, with 144 (28.1%) tested at 12 
(±1) months. Eighty-eight (17.2%) infants received 
both tests as specified in the national guidelines.
Twenty-one (4.1%) infants were documented as 
HIV-infected, and all had been started on ART by the 
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Prevention of mother-to-child transmission ‘Option B+’ 
originated in Malawi in 2011 to prevent new infections in 
infants exposed to the human immunodeficiency virus 
(HIV). We assessed 12-month programme retention and 
HIV testing uptake among infants born to HIV-infected 
mothers from September 2011 to June 2012 in Thyolo 
District Hospital. Of 513 infants, 368 (71.7%) remained 
in care at 12 months. Altogether, 412 (80.3%) under-
went HIV DNA polymerase chain reaction testing, with 
267 (52.0%) tested at 6–12 weeks, and 255 (49.7%) un-
derwent rapid HIV testing, with 144 (28.1%) tested at 12 
months. Eighty-eight (17.2%) infants had both tests as 
scheduled. Measures are needed to improve adherence 
to national testing protocols.
TABLE 1 12-month outcomes in children born to 
HIV-infected mothers in Thyolo District Hospital, Malawi, 
October 2011–June 2012 
Outcome 
at 12 (±1) months n (%)
Retained in care 368 (71.7)
Lost to follow-up 86 (16.8)
Transferred out 48 (9.4)
Stopped treatment 8 (1.6)
Died 3 (0.6)
 Total 513 (100)
HIV = human immunodeficiency virus.
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age of 12 months. Of the 21 infants, HIV infection was 
diagnosed by PCR in 13 (2.5%) and by RHT in eight 
(1.5%).
DISCUSSION
This is the first study to report on 12-month pro-
gramme retention and adherence to HIV testing rec-
ommendations in infants enrolled in Option B+ in 
TDH. Over 70% of children remained in care at 12 
months, but <20% of infants were recorded as having 
received both HIV tests at specified times. There is 
therefore room for improvement in the uptake of PCR 
testing at 6–12 weeks and RHT at 12 months. An ongo-
ing Option B+ programme evaluation in Thyolo Dis-
trict found that between April and June 2013, 80% of 
infants born to HIV-infected mothers who had en-
rolled in Option B+ during pregnancy had undergone 
PCR testing between 5 and 13 weeks.5
More emphasis is needed to address the program-
matic challenges that prevent health providers from 
offering HIV testing to infants according to protocol. 
This includes building human resource capacity, ad-
dressing health staff and testing kit shortages, ensuring 
that no opportunities for testing are missed, that all 
tests are recorded on the infant´s clinic card at the 
time of sample collection, and follow-up of unreported 
test results with the laboratory. In addition, qualitative 
research would help to identify reasons for lack of ad-
herence to HIV testing protocols so that current defi-
ciencies can be addressed and to understand mothers´ 
barriers to accessing Option B+.
A limitation of this study is the completeness of 
routinely collected programme data: 236 results of 
PCR testing at 6–8 weeks were not captured. It was not 
possible to ascertain whether infants without PCR re-
sults were not tested, were tested but the result not re-
ceived, or were tested and the result was received but 
not documented. In addition, the HIV status of the 
125 infants who were transferred to another facility or 
lost to follow-up before the age of 12 months was not 
documented. Registers to log infant PCR results were 
introduced nationally by the MoH at the beginning of 
2013. As these registers only record test results and do 
not identify infants due for PCR testing or those await-
ing test results, additional measures are needed to en-
sure that all HIV-exposed infants are tested.
Option B+ was conceived with the vision of elimi-
nating new cases of HIV infection among children. 
Early results show adequate uptake and retention of 
pregnant and breastfeeding women in Option B+,8,9 and 
this study shows good results for programme retention 
among HIV-exposed infants. It is likely that HIV infec-
tions in infants will decrease and that follow-up of ex-
posed infants will improve over time, as, by removing 
the gating CD4 step from the HIV care cascade, more 
mothers will receive ART.2,10 It is important to perform 
HIV testing according to schedule, to keep a record of 
all specimens sent for PCR testing to the Central Labo-
ratory in Queen Elizabeth Hospital in Blantyre, and to 
follow up on missing results. It would also be useful to 
conduct further research to ascertain the reasons for the 
high proportion of infants with missing HIV test results, 
and the reasons for loss to follow-up.
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TABLE 2 HIV testing performed according to national guidelines in children born to HIV-infected mothers in Thyolo 
District Hospital, Malawi, October 2011–June 2012
Type of test
HIV tests not 
documented
n (%)
HIV tests documented
Timing according to 
guidelines
n (%)*
Timing not according 
to guidelines
n (%)
Timing of testing 
unknown
n (%)
Total tests 
documented
n (%)
HIV DNA- 
 PCR*
99 (19.3) 267 (52.0) 122 (23.8) 25 (4.9) 414 (80.7)
Rapid HIV 
 test*
258 (50.3) 144 (28.1) 102 (19.9) 9 (1.7) 255 (49.7)
Both tests 309 (60.2)† 88 (17.2) 95 (18.5) 21 (4.1) 204 (39.8)
* HIV DNA-PCR is a test performed at 6–12 weeks in HIV-exposed infants in compliance with national guidelines. Rapid HIV testing using serology 
dipstick methodology is performed in compliance with national guidelines at 12 (±1) months.
† At least one of the two tests not done.
HIV = human immunodeficiency virus; DNA-PCR = DNA-polymerase chain reaction.
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L’option B+ de la prévention de la transmission mère-enfant a débuté 
au Malawi en 2011 afin de prévenir de nouvelles infections chez les 
enfants exposés au virus de l’immunodéficience humaine (VIH). Nous 
avons évalué un programme de 12 mois de rétention et de réalisation 
du test VIH parmi les bébés nés de mères VIH-positives de septembre 
2011 à juin 2012 à l’hôpital de district de Thyolo. Sur 513 nourrissons, 
368 (71,7%) sont restés en soins pendant 12 mois. Au total, 412 
bébés (80,3%) ont bénéficié d’une recherche de VIH par ADN-PCR ; 
267 (52%) ont été testés entre 6 et 12 semaines et 255 (49,7%) ont 
eu un test rapide, dont 144 (28,1%) testés à 12 mois. Quatre-vingt-
huit bébés (17,2%) ont eu deux tests comme prévu. Il est nécessaire 
d’améliorer l’adhésion aux protocoles nationaux de dépistage.
En el 2011 se puso en marcha en Malawi la estrategia Opción B+ de 
prevención de la transmisión maternoinfantil, con el fin de evitar 
nuevas infecciones por el virus de la inmunodeficiencia humana (VIH) 
en los lactantes expuestos. Se evaluó durante un período de 12 
meses, entre septiembre del 2011 y junio del 2012, la fidelización al 
programa y la práctica de la prueba diagnóstica del VIH a los lactantes 
de madres infectadas por el VIH en el Hospital Distrital de Thyolo. De 
los 513 lactantes expuestos atendidos durante el período del estudio, 
368 continuaban en el programa a los 12 meses (71,7%). En total, se 
practicó la prueba del VIH mediante la reacción en cadena de la 
polimerasa (PCR-ADN) a 412 lactantes (80,3%); en 267 niños la 
prueba se realizó entre las 6 y las 12 semanas de edad (52,0 %). La 
prueba serológica rápida del VIH se practicó en 255 lactantes (49,7%) 
y en 144 de estos casos a los 12 meses (28,1%). Ochenta y ocho 
niños recibieron ambas pruebas, en conformidad con las pautas del 
programa. Es preciso adoptar medidas encaminadas a mejorar el 
cumplimiento de los protocolos nacionales en materia de pruebas 
diagnósticas del VIH.
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